A Rare Case of Embryonal Carcinoma in a Patient with Turner Syndrome without Y Chromosomal Material but Mutations in KIT, AKT1, and ZNF358 Demonstrated Using Exome Sequencing

Claus H Gravholt, Ole L Dollerup, Lone Duval, Else Mejlgaard, Katrine Stribolt, Søren Vang, Britt E Laursen, Michael Knudsen, Kasper Thorsen, Remko Hersmus, Leendert H J Looijenga, Kirstine Stochholm

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

9 Citations (Scopus)

Abstract

Gonadoblastoma and malignant transformations thereof can occur in females with Turner syndrome (TS) and Y chromosomal material. However, in females with TS and no Y chromosomal material, this is rarely seen. We report a female with an apparent 45,X karyotype (in blood and tumor) who was diagnosed with a metastatic embryonal carcinoma. Exome sequencing of blood and the tumor was done, and no Y chromosomal material was detected, while predicted deleterious mutations in KIT (likely driver), AKT1, and ZNF358 were identified in the tumor. The patient was treated with chemotherapy (first-line: cisplatin, etoposide, and bleomycin; second-line: paclitaxel and gemcitabine), and after that surgical debulking was performed. She is currently well and without signs of relapse. We conclude that embryonal carcinoma can apparently occur in 45,X TS without signs of Y chromosomal material.

Original languageEnglish
JournalSexual Development
Volume11
Issue5-6
Pages (from-to)262-268
Number of pages7
ISSN1661-5425
DOIs
Publication statusPublished - 2018

Keywords

  • 45,X
  • CANCER
  • CLINICAL-PRACTICE GUIDELINES
  • DIAGNOSIS
  • Dysgerminoma
  • FEATURES
  • FEMALE
  • GERM-CELL TUMORS
  • GONADOBLASTOMA
  • Germ cell neoplasia in situ
  • Gonadoblastoma
  • MALIGNANCY
  • MARKERS
  • UPDATE

Fingerprint

Dive into the research topics of 'A Rare Case of Embryonal Carcinoma in a Patient with Turner Syndrome without Y Chromosomal Material but Mutations in KIT, AKT1, and ZNF358 Demonstrated Using Exome Sequencing'. Together they form a unique fingerprint.

Cite this